Skip to main content
. 2024 May 7;15:288–300. doi: 10.18632/oncotarget.28583

Table 5. Linear mixed-effects models for assessing impact of lesion features on relative difference in SUV metrics.

Model SUV metric Fixed effect beta std error t statistic p-value
V1 SUVmean Base ref
Original SUVmean −0.636 0.172 −3.71 2.56E-04
HUmean 0.020 0.014 1.42 0.154
HUmax 1.20E-04 5.69E-05 2.11 0.035
Volume −0.128 0.122 −1.04 0.296
Location Bone 6.79 4.99 1.36 0.075
Other 30.9 17.7 1.75
Prostate 12.2 6.35 1.92
PSMARADS 5 −8.20 3.80 −2.16 0.032
SUVmax Base ref
Original −0.384 0.101 −3.80 1.78E-04
HUmean 0.027 0.014 1.85 0.065
HUmax 0.014 0.006 2.36 0.019
Volume −0.141 0.129 −1.10 0.273
Location Bone 11.4 5.22 2.19 0.060
Other 32.1 18.5 1.73
Prostate 6.38 6.63 0.962
PSMARADS 5 −10.9 3.97 −2.74 0.007
V2 SUVmean Base ref
Original SUVmean −0.410 0.190 −2.15 3.20E-02
HUmean 0.023 0.015 1.55 0.120
HUmax 0.013 0.006 2.06 0.040
Volume −0.134 0.133 −1.01 0.314
Location Bone 9.21 5.40 1.71 0.084
Other 37.9 19.2 1.97
Prostate 7.47 6.86 1.09
PSMARADS 5 −9.56 4.13 −2.32 0.021
SUVmax Base ref
Original −0.252 0.119 −2.12 3.51E-02
HUmean 0.019 0.017 1.14 0.253
HUmax 0.011 0.007 1.53 0.127
Volume −0.147 0.149 −0.986 0.324
Location Bone 10.4 6.00 1.73 0.059
Other 39.7 21.4 1.86
Prostate −0.313 7.61 −0.411
PSMARADS 5 −7.92 4.63 −1.71 0.088

Base model: Rel.Diff ~ (1|patient). Evaluated models: Rel.Diff ~ <variable> + (1|patient). Statistical significance relative to base model determined from ANOVA.